#United States #Alameda #Avian Influenza #Alveo Technologies #Royal GD

Alveo Technologies and Royal GD to Expand Poultry Testing Portfolio

Alveo Technologies, a leading name in molecular diagnostics, is making headlines with its recent partnership expansion with Royal GD, a renowned animal health authority. This enhanced collaboration aims to broaden the poultry testing portfolio, particularly focusing on not only avian influenza but also other critical respiratory diseases affecting poultry production.

Enhanced Rapid Testing Capabilities

With the success of the Alveo Sense™ avian influenza test already in the market, both organizations are set to co-develop additional molecular tests specifically tailored to identify notifiable diseases and avian respiratory illnesses that mimic avian influenza. The primary goal is to provide poultry farmers with quick, accurate diagnoses, enabling timely interventions that can prevent extensive losses and manage the health of their flocks effectively.

Shaun Holt, CEO of Alveo, expressed optimism about this collaboration, emphasizing the shared commitment to meet the rising demand for rapid diagnostics at the Point of Need™. He noted, “Great partners bring great possibilities,” highlighting their vision to develop tests for a variety of pathogens while building on Alveo’s innovative testing platform.

The Technology Behind the Testing

Central to this initiative is Alveo’s patented IntelliSense™ technology, a molecular detection system that utilizes direct electrical sensing of nucleic acid amplification. This breakthrough makes it possible to achieve lab-quality results within an hour, right on the farm, without the need for lengthy logistical arrangements common with traditional lab-based testing. This mobile testing solution is compact and reusable, facilitating easy field assessments across multiple pathogens in a single cartridge.

Current testing methods often require samples to be transported to centralized labs, which can lead to delays of days or even weeks before results are available. Such delays impede essential decisions regarding flock management, including culling infected birds, vaccination, or administering antibiotics, which are crucial for maintaining animal health and biosecurity.

Rapid Decision-Making in a Changing Landscape

The global poultry industry is facing increasing pressures due to climate change and international trade, alongside the proliferation of diseases such as avian influenza and Newcastle disease. Royal GD’s Wim Kieftenbeld reinforced the urgency of this collaboration, stating, “We’ve doubled our RD commitment to get these new panels into the field quickly.” Their concerted efforts reflect a proactive approach to agriculture during a time when poultry production is under constant threat.

By integrating advanced diagnostic capabilities directly into the field, Alveo and Royal GD aim to deliver solutions that facilitate rapid decision-making and minimize the economic impacts of poultry diseases. Their partnership embodies a shift towards a more proactive and tech-driven approach to animal health, focusing on effective and timely responses to emerging threats.

Looking to the Future

Moving forward, the partnership between Alveo and Royal GD is expected to redefine standards in poultry health management and biosecurity. Both organizations are poised to set new benchmarks for rapid molecular diagnostics in agriculture, ensuring that farmers can respond swiftly to health challenges, maintain productivity, and ultimately safeguard food security.

Alveo continues to lead the charge in making molecular diagnostics accessible globally, aiming to reshape the way diseases are detected and managed across various industries. Their model emphasizes the importance of getting results swiftly, allowing stakeholders to act faster—with the motto “Know Sooner, Act Faster™.”

To learn more about Alveo Technologies, visit their official website or follow their updates on LinkedIn. Royal GD, with over a century of expertise in animal health, collaborates seamlessly with Alveo to ensure that both technology and veterinary knowledge align for the best outcomes in animal health management.